Acknowledgements The authors would like to thank the Stanford University Veterinary Service Center for their assistance and care of animals used in this study, and Ben Franco and Kaleigh Beacham for their support with collection of blood
But for musculoskeletal injuriestendons, ligaments, musclesthe bioavailability of oral BPC 157 to the rest of the body is significantly lower than injectable forms

Red flag symptoms that necessitate same-day medical contact include: Blood in stools (visible red blood or black, tarry stools) Severe abdominal pain that is persistent, severe, or radiating to the back (which may indicate pancreatitis, a rare but serious side effect) Signs of dehydration : decreased urination, dark urine, dizziness upon standing, extreme thirst, or confusion Fever above 100.4F (38C) accompanying diarrhea Pain in the upper right abdomen , possibly with fever or yellowing of skin/eyes (signs of gallbladder disease, which can occur with GLP-1 medications) Inability to keep down fluids due to concurrent vomiting If you experience severe vomiting or diarrhea leading to dehydration, you may need to temporarily pause your medication until speaking with your healthcare provider, as severe dehydration can lead to acute kidney injury
02105-1/asset/8468e457-0c7f-4e4c-9b6d-2202dbefa9cb/main.assets/gr1_lrg.jpg)
(J Physiol Pharmacol, 2013) found that oral BPC-157 at 10 mcg/kg daily reduced ulcer size by 60% over 14 days, while injectable BPC-157 at the same dose achieved 85% reduction
What the Evidence Shows and What It Does Not The Gallup obesity and GLP-1 data are drawn from self-reported surveys, which introduces known limitations
After just two weeks with Timilk, the inflammation completely cleared up